📰 Effect Sizes News

Effect Sizes News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Effect Sizes. Real-time updates on events, politics, business and more.

Axsome to Present Results of SHARP Study at Psych Congress

September 8, 2023

Axsome is set to present new data on Sunosi (solriamfetol) in patients with excessive daytime sleepiness (EDS) due to narcolepsy and OSA.

David Gozal Johannes Gutenberg Craig Chepke Hans Van Dongen Washington State University Axsome Therapeutics Inc

Source: sleepreviewmag.com

Axsome Therapeutics Highlights Commitment to Innovating Treatments for Mental Health Conditions with Presentations at Psych Congress 2023

September 7, 2023

Data presentations explore effects on patient-centric efficacy measures of treatments for patients with depression, and excessive sleepiness associated with obstructive sleep apnea and narcolepsy NEW...

New York United States Mark Jacobson Darren Opland Andrew Cutler Manish Jha

Source: marketscreener.com

Axsome to Present New Sunosi Data at SLEEP 2023

June 2, 2023

Axsome Therapeutics Inc will present new data on Sunosi (solriamfetol) at SLEEP 2023, including results from the SHARP study.

United Kingdom Russell Rosenberg Hans Van Dongen Johannes Gutenberg Department Of Neurology Axsome Therapeutics Inc

Source: sleepreviewmag.com

Axsome Therapeutics to Present New Sunosi® Data at SLEEP 2023

June 1, 2023

Cognitive improvement with Sunosi sustained over eight hours in patients with excessive daytime sleepiness due to obstructive sleep apneaNEW YORK, June 01, 2023 -- Axsome Therapeutics, Inc. , a... | June 1, 2023

United Kingdom United States New York Darren Opland Hans Van Dongen Johannes Gutenberg

Source: marketscreener.com